Saama’s Smart Data Quality for Clinical Analytics Named Leading AI Solution in Cloud Computing

Saama’s Smart Data Quality for Clinical Analytics Named Leading AI Solution in Cloud Computing

CAMPBELL, CA – (September 27, 2022) Saama today announced that Smart Data Quality (SDQ), its transformative artificial intelligence (AI) engine that accelerates data cleaning and generates and solves clinical trial queries on the fly, was awarded a 2022 Stratus Award for Cloud Computing. The Business Intelligence Group confers Stratus Awards in recognition of products and companies that are innovating in the cloud and providing truly differentiated marketplace offerings.

A domain-centric, machine learning technology that automates and accelerates data management processes, SDQ reduces the cycle time from data entry to query generation by 95%, thanks to its ability to automatically identify data discrepancies with high accuracy. SDQ improves operational efficiency by reducing human effort in discrepancy identification and helps to uncover data mismatches often missed by human review.

“SDQ has accelerated drug delivery, empowering our customers to deliver life-saving medications and therapies to patients faster,” said Vivek Sharma, Chief Executive Officer, Saama. “The Stratus Award acknowledges the trust, courage and commitment of our customers and of our product and engineering teams.”

SDQ was integral in expediting the development of the world’s first COVID-19 vaccine. SDQ processed over 100 million data points per day for Pfizer’s 47,000-person clinical trial, reduced clinical development by one month, and ensured analysis-ready data 22 hours after meeting primary efficacy case counts.

About Saama 

Saama is the life science industry leader of ClinTech, the new category of purpose-built, AI-based clinical insights and automation platforms empowering faster, safer clinical development and regulatory programs. Over 50 biotech companies–including many top 20 pharmaceutical companies–use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform to accelerate over 1,500 studies, including the clinical trial for the world’s first COVID-19 vaccine. LSAC’s rich applications facilitate unprecedented, authoritative oversight and automation of comprehensive clinical research data, enabling companies to file New Drug Applications (NDAs) more efficiently and bring treatments to patients sooner. Discover more: www.saama.com. Follow @SaamaTechInc on Twitter.